GRCE NASDAQ
Grace Therapeutics, Inc.
1W: -2.4%
1M: -3.3%
3M: -18.2%
YTD: -43.4%
1Y: -32.6%
$2.07
+0.03 (+1.47%)
Weekly Expected Move ±5.6%
$2
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-9M
Net Income
-177.7% YoY
$-9M
Free Cash Flow
-25.6% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-13.8%
ROA-13.0%
ROIC-21.9%
Valuation
P/E-1.6
P/B0.7
EV/EBITDA-4.6
Leverage
Debt/Equity0.00
Current Ratio8.10
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z11.46
Beneish M0.00